|
Re: Abstract - first example of a "curative" effect?
|
3
|
Resverlogix Corp.
|
Oct 11, 2018 05:42AM
|
|
Re: ACC 2019 Abstracts
|
2
|
Resverlogix Corp.
|
Mar 19, 2019 12:10PM
|
|
Re: ACC 2019 Abstracts
|
2
|
Resverlogix Corp.
|
Mar 19, 2019 12:18PM
|
|
Re: ACC 2019 Abstracts
|
2
|
Resverlogix Corp.
|
Mar 19, 2019 01:25PM
|
|
Re: AHA 2018
|
2
|
Resverlogix Corp.
|
Nov 11, 2018 08:53AM
|
|
Re: AHA 2018
|
5
|
Resverlogix Corp.
|
Nov 11, 2018 10:41AM
|
|
Re: AHA 2018
|
4
|
Resverlogix Corp.
|
Nov 11, 2018 11:46PM
|
|
Re: AHA 2018
|
4
|
Resverlogix Corp.
|
Nov 12, 2018 09:22AM
|
|
Re: AHA 2018
|
3
|
Resverlogix Corp.
|
Nov 12, 2018 11:49AM
|
|
Re: AHA 2018
|
5
|
Resverlogix Corp.
|
Nov 10, 2018 11:04PM
|
|
Re: AHA 2018
|
3
|
Resverlogix Corp.
|
Nov 11, 2018 05:03AM
|
|
Re: Amarin / Mineral Oil
|
4
|
Resverlogix Corp.
|
Nov 10, 2018 03:57PM
|
|
Re: Amarin / Mineral Oil
|
5
|
Resverlogix Corp.
|
Nov 10, 2018 04:20PM
|
|
Re: Amarin CEO interview
|
4
|
Resverlogix Corp.
|
Nov 12, 2018 02:35PM
|
|
Re: Amarin CEO interview - New class action lawsuit
|
5
|
Resverlogix Corp.
|
Nov 14, 2018 08:13PM
|
|
Re: Another Indication ?
|
1
|
Resverlogix Corp.
|
May 11, 2019 10:55AM
|
|
Re: Antibodies Against Microglial Receptors TREM2 and CD33 Head to Trials
|
6
|
Resverlogix Corp.
|
May 11, 2019 07:04AM
|
|
Re: Anyone have $285000
|
1
|
Resverlogix Corp.
|
May 08, 2019 01:47PM
|
|
Re: Are statins overprescribed? Why the risks and benefits are so complex / Pitavastatin
|
3
|
Resverlogix Corp.
|
Dec 04, 2018 08:37PM
|
|
Re: Are statins overprescribed? Why the risks and benefits are so complex / Pitavastatin
|
2
|
Resverlogix Corp.
|
Dec 04, 2018 09:19PM
|
